A business in context

APYX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-29 · 0001437749-26-031468 · Items 8.01,9.01

  2. 8-K · Current report

    Report date 2026-08-06 · 0001493152-26-036557 · Items 5.02,5.07,9.01

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-026346

  4. 8-K · Current report

    Report date 2026-08-06 · 0001437749-26-026262 · Items 2.02,9.01

  5. 8-K · Current report

    Report date 2026-07-24 · 0001493152-26-034619 · Items 8.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-30 · 0001493152-26-031944

  7. DEF 14A · Proxy statement

    Report date 2025-12-31 · 0001437749-26-021840

  8. 4 · Ownership change

    Report date 2026-06-15 · 0001493152-26-029122

  9. 8-K · Current report

    Report date 2026-06-11 · 0001493152-26-029081 · Items 1.01,9.01

  10. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028781

  11. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028771

  12. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028770

  13. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028769

  14. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028768

  15. 4 · Ownership change

    Report date 2026-06-11 · 0001493152-26-028767

  16. 8-K · Current report

    Report date 2026-05-21 · 0001437749-26-018098 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-05-14 · 0001437749-26-016885 · Items 8.01,9.01

  18. 8-K · Current report

    Report date 2026-05-11 · 0001437749-26-016000 · Items 8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015652

  20. 8-K · Current report

    Report date 2026-05-07 · 0001437749-26-015352 · Items 2.02,9.01

  21. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-007471

  22. 8-K · Current report

    Report date 2026-03-10 · 0001437749-26-007420 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2026-01-12 · 0001437749-26-001048 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-12-08 · 0001493152-25-027481 · Items 5.03,9.01

  25. 8-K · Current report

    Report date 2025-11-17 · 0001493152-25-024279 · Items 1.01,8.01,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-033499

  27. 8-K · Current report

    Report date 2025-11-06 · 0001437749-25-033456 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-08-07 · 0001641172-25-023451 · Items 5.07

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-025422

  30. 8-K · Current report

    Report date 2025-08-07 · 0001437749-25-025417 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2024-12-31 · 0001437749-25-021220

  32. 8-K · Current report

    Report date 2025-05-13 · 0001437749-25-016259 · Items 8.01,9.01

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-015356

  34. 8-K · Current report

    Report date 2025-05-08 · 0001437749-25-015231 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-04-29 · 0001437749-25-013413 · Items 8.01,9.01

  36. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-007521

  37. 8-K · Current report

    Report date 2025-03-13 · 0001437749-25-007383 · Items 2.02,9.01

  38. 8-K · Current report

    Report date 2025-01-31 · 0001437749-25-003036 · Items 5.02,9.01

  39. 8-K · Current report

    Report date 2025-01-13 · 0001437749-25-000927 · Items 2.02,9.01

  40. 8-K · Current report

    Report date 2025-01-06 · 0001437749-25-000375 · Items 8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 2 transaction rows2MTax / exercise payment: 1 transaction rows1FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

3 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-30
2026-07-02
Waldman LawrenceM · Exercise / conversion
Acquired
Common Stock12000.01.88
2026-06-30
2026-07-02
Waldman LawrenceF · Tax / exercise payment
Disposed
Common Stock5024.04.49
2026-06-30
2026-07-02
Waldman LawrenceM · Exercise / conversion
Disposed
Stock option (right to buy)
Derivative security
12000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0000719135Apyx Medical Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • BOVIE MEDICAL CORP · former SEC name · 2015-03-27 to 2019-01-02
  • BOVIE MEDICAL Corp · former SEC name · 2015-03-27 to 2019-01-02
  • AN CON GENETICS INC · former SEC name · 1995-12-28 to 1999-01-13

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$48.10M$51.67M
2023-12-31$52.35M$57.88M
2022-12-31$44.51M$51.24M
2021-12-31$48.52M$60.32M
2020-12-31$27.71M$36.08M
2019-12-31$28.23M$37.21M
2018-12-31$16.61M$22.28M
2017-12-31$10.23M$14.07M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗